Pharming Group (OTCMKTS:PHGUF – Get Free Report) reached a new 52-week low on Monday . The company traded as low as $0.95 and last traded at $0.95, with a volume of 0 shares trading hands. The stock had previously closed at $0.95.
Pharming Group Price Performance
The stock has a 50 day simple moving average of $1.15 and a two-hundred day simple moving average of $1.16. The firm has a market cap of $619.79 million, a PE ratio of -95.00 and a beta of 1.07. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.33 and a current ratio of 4.06.
About Pharming Group
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks.
Read More
- Five stocks we like better than Pharming Group
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- High-Yield Texas Instruments Could Hit New Highs Soon
- What is the Australian Securities Exchange (ASX)
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Read Stock Charts for Beginners
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
